CWP232228 sodium is a novel and selective Wnt/β-Catenin inhibitor that antagonizes binding of β-catenin to T-cell factor (TCF) in the nucleus. It preferentially inhibits the growth of breast cancer stem-like cells. CWP232228 targets liver cancer stem cells through Wnt/β- a novel therapeutic approach for liver cancer treatment.

纯度：≥98%

CAS：1144044-02-9